The Latest Breaking News from CVS

It comes as first-half profits leapt by 50% to £53.9 million.

Warning letters sent to the companies claimed certain products they sell are ‘especially concerning from a public health perspective’

These outperformers are all trading under $10 per share - for now. After beating the S&P 500 year-to-date, analysts think these standout single-digit stocks all have room to keep running higher.

New CVS unit aims to cut your prescription costs by offering alternatives to branded drugs.

Ana Walshe’s body has not been found, but prosecutors are trying to prove that her husband, Brian Walshe, murdered and dismembered the mother-of-three

With rising healthcare spending, the drugstore industry is poised to witness solid growth amid heightened demand. As a result, leading industry players CVS Health (CVS), Walgreens Boots Alliance (WBA), and Rite Aid (RAD) stand to benefit. However, should you Buy, Hold, or Sell these stocks? Keep reading to find out.

Uninsured can get their COVID-19 shots at community and state health departments, but a partnership with pharmacies is still in the works.

The medical sector is expected to grow amid steady demand and technological advancements. So, let's analyze which of these stocks, CVS Health (CVS), Walgreens Boots Alliance (WBA), and TRxADE HEALTH (MEDS), has the better growth opportunities.

Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are down -0.61%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are down -0.88%. Stock indexes this morning are lower after Fitch Ratings’ downgrade of U.S. government debt spurred a risk-off sentiment in stocks. Stocks are also under pressure...